Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Document › Details

Kiadis Pharma N.V.. (3/12/18). "Press Release: Kiadis Pharma Launches a Private Placement of Approximately 2.6 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction in which Unlawful]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Jefferies International Ltd.
  Group Leucadia (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 investment banking
Index term Index term Kiadis–SEVERAL: investment, 201803 private placement €23.4m w 2.6m new shares €9/share to institutional investors
Person Person Hård, Karl (Kiadis 201709–201812 Head IR + Communications LEFT 1/19 before Redx Pharma + AstraZeneca)
     


   
Record changed: 2018-03-31

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Kiadis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top